您要查找的是不是:
- They were divided by HBsAg and HBV DNA into 4 groups. 按血清HBsAg及乙肝病毒脱氧核糖核酸(HBV DNA)检测结果分组。
- Objective:To study the relationship between HBV M and HBV DNA. 目的:研究乙肝病毒血清学标志物(HBV M)与乙肝病毒脱氧核糖核酸(HBV DNA)之间的关系。
- A COMPARATAREL STUDY OF PCR FOR HBV DNA AND ELISA FOR HBV MARKERS. PCR法检测食品从业人员血清中的HBV-DNA与ELISA法检测结果比较
- HBV DNA was observed both in the cytoplasm and nuclei of hepatocytes. HBVDNA可见于受染肝细胞的胞核或胞浆内,而HDVRNA绝大部分见于肝细胞胞核。
- Relationship of HBV DNA and serum HBV marks in patients with hepatitis B. 水平与血清标志物的关系。
- The relationship between the amount of HBV DNA in serum and HBV markers. 乙型肝炎病毒DNA含量与血清标志物的关系。
- Analysis of correlation among HBV DNA, HBV preS1 antigen and HBV markers. 乙肝病毒DNA和前S1抗原及其标记物三者相关性分析
- LHBs of 171 CHB patients were not statistically different from HBV DNA(P>0.05). 171份乙肝患者HBV DNA、LHBs的检测结果显示:LHBs的检测结果与HBV DNA的检出结果差异无统计学意义(P>0.;05)。
- Results The positive rate of HBVDNA was 56.7%,and the level of HBV DNA was 4.16+0.57(LogE,copies/ml)in saliva. 结果60例慢性HBV 感染者中唾液HBV DNA 阳性34例;平均HBV DNA 含量为4.;16±0
- Quantitative detection of serum HBV DNA is useful in assessment of liver damage and guidance in antivirus therapy. 定量检测HBVDNA对判断肝损害程度、指导抗病毒治疗有重要意义
- The percent age of HBV DNA(+)in patients with both eAg (-) and eAb(+) was 26.13%. eAg(-)同时eAb(+)者中HBVDNA(+)占26.;13%25。
- The positive patients for HBV DNA and in china HCV antibody were 75.0% and 38.5% respectively. 我们采用聚合酶链反应技术和ELISA法检测了52例原发性肝细胞癌患者血清乙型肝炎病毒脱氧核糖核酸(HBVDNA)及抗丙型肝炎病毒(HCV),阳性率分别为75.;0%25,38
- The relationship between AFP and ALT, AST and HBV DNA was analyzed by correlation analysis. 采用相关分析法分析AFP与血清丙氨酸转氨酶 (ALT)和血清门冬氨酸转氨酶 (AST)以及AFP与HBVDNA之间的关系。
- In 42 cases recovery model group(RMG) samples,4 cases were HBV DNA positive with a positive rate of 9 52%. 恢复期模式组有42例;但仍可检出HBVDNA4例;阳性率为9.;52%25;
- The serum HBV DNA become undetectable(<300 copies/ml by PCR)in 76% of ETV group versus 43% of LVD group(P<0.0001). 用PCR法;ETV组中有76%25的患者测不到病毒(<300拷贝/ml);而LVD组中仅为43%25。
- According to clinical analysis , the positive rate of HBV DNA is HLC ( 85.5% ) > CH ( 76.5% ) > AH ( 12.5% ). 按临床分型;HBV DNA阳性率为HLC(85.;0%25)>CH(76
- It is not accordant that HBsAg, anti-HBc and anti-HBe were compared with serum HBV DNA. HBsAg、抗-HBc及抗-HBe与血清HBV DNA并非一致。
- To construct a therapeutic HBV DNA vaccine and investigate its expression in mammalian cells. 摘要目的构建一种治疗性的乙肝DNA疫苗并测定它的表达。
- HBV was sequenced for all patients with detectable HBV DNA (>1000 copies/ml, Amplicor PCR) at baseline and week 96. 对所有病人进行HBV测序,在基线水平检测其HBV DNA(>1000拷贝/ml,Amplicor PCR)并观察96周。
- Quantitative analysis of HBV DNA PCR was performed by Roche Lightcycler fluoresencent quantitative amplification analyzer which made in Germany. HBV DNA定量pcr以德国Roche L ightcyc ler荧光定量扩增仪检测;